Encouraging expanded domestic manufacturing capacity in Canada for select drugs so that there are more than one producer for key medicines is among the actions that are up for discussion in a consultation document from Health Canada on how prevent drug shortages.
Requiring risk management plans for shortages in certain situations and exploring the use of digital strategies to gather information across the supply chain are also
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?